Search Results

You are looking at 51 - 60 of 165 items for :

  • "early breast cancer" x
  • All content x
Clear All
Full access

Jagar Jasem, Christine M. Fisher, Arya Amini, Elena Shagisultanova, Rachel Rabinovitch, Virginia F. Borges, Anthony Elias, and Peter Kabos

. J Natl Cancer Inst 2001 ; 93 : 979 – 989 . 3. Goldhirsch A Wood WC Gelber RD . Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer . J Clin Oncol 2003 ; 21 : 3357 – 3365 . 4

Full access

Robert W. Carlson, Susan Moench, Arti Hurria, Lodovico Balducci, Harold J. Burstein, Lori J. Goldstein, William J. Gradishar, Kevin S. Hughes, Mohammad Jahanzeb, Stuart M. Lichtman, Lawrence B. Marks, Joan S. McClure, Beryl McCormick, Lisle M. Nabell, Lori J. Pierce, Mary Lou Smith, Neal S. Topham, Tiffany A. Traina, John H. Ward, and Eric P. Winer

-positive breast tumors. Radiation Therapy The meta-analyses of radiotherapy trials by the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) showed that the 5-year absolute reduction in local recurrences associated with radiation therapy after breast

Full access

Julie R. Gralow, J. Sybil Biermann, Azeez Farooki, Monica N. Fornier, Robert F. Gagel, Rashmi N. Kumar, Charles L. Shapiro, Andrew Shields, Matthew R. Smith, Sandy Srinivas, and Catherine H. Van Poznak

N Coleman R . Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole . Oncologist 2008 ; 13 : 503 – 514 . 56 Gnant

Full access

Robert W. Carlson, D. Craig Allred, Benjamin O. Anderson, Harold J. Burstein, W. Bradford Carter, Stephen B. Edge, John K. Erban, William B. Farrar, Andres Forero, Sharon Hermes Giordano, Lori J. Goldstein, William J. Gradishar, Daniel F. Hayes, Clifford A. Hudis, Britt-Marie Ljung, David A. Mankoff, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Lori J. Pierce, Elizabeth C. Reed, Jasgit Sachdev, Mary Lou Smith, George Somlo, John H. Ward, Antonio C. Wolff, and Richard Zellars

treatment should not be compromised when decisions regarding breast reconstruction are made. Systemic Adjuvant Therapy After surgical treatment, adjuvant systemic therapy should be considered. The published results of the Early Breast Cancer

Full access

Gary H. Lyman

efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials . Lancet Oncol 2005 ; 6 : 669 – 677 . 34 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an

Full access

Benjamin O. Anderson, Kristine E. Calhoun, and Eric L. Rosen

the breast . Hum Pathol 1992 ; 23 : 1167 – 1171 . 54. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group [see comments] . Lancet 1998 ; 351 : 1451 – 1467

Full access

Puyao C. Li, Zilu Zhang, Angel M. Cronin, and Rinaa S. Punglia

–specific survival is compromised among women who hvae an ipsilateral invasive cancer diagnosis after DCIS. 8 The Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) meta-analysis of 3,729 women with DCIS enrolled in 4 randomized trials included 92 women who

Full access

William J. Gradishar

Handley K . aTTom: long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer [abstract] . J Clin Oncol 2013 ; 31 ( Suppl ): Abstract 5 . 10. Mamounas EP Bandos H

Full access

Martin C. Mahoney

. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial . Lancet 2002 ; 359 : 2131 – 2139 . 37. Moorman PG

Full access

Mei-Chin Hsieh, Lu Zhang, Xiao-Cheng Wu, Mary B. Davidson, Michelle Loch, and Vivien W. Chen

cancer subtypes, and survival in the Carolina Breast Cancer Study . JAMA 2006 ; 295 : 2492 – 2502 . 10.1001/jama.295.21.2492 16757721 6. Early Breast Cancer Trialists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast